
Cancel anytime
- Chart
- Upturn Summary
- Highlights
Upturn AI SWOT
- About
Global X Aging Population ETF (AGNG)



- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)


(see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
10/14/2025: AGNG (1-star) has a low Upturn Star Rating. Not recommended to BUY.
Analysis of Past Performance
Type ETF | Historic Profit 25.56% | Avg. Invested days 75 | Today’s Advisory Consider higher Upturn Star rating |
Upturn Star Rating ![]() ![]() | Upturn Advisory Performance ![]() | ETF Returns Performance ![]() |
![]() ![]() | ![]() ![]() |
Key Highlights
Volume (30-day avg) - | Beta 0.69 | 52 Weeks Range 27.30 - 33.33 | Updated Date 06/29/2025 |
52 Weeks Range 27.30 - 33.33 | Updated Date 06/29/2025 |
Upturn AI SWOT
Global X Aging Population ETF
ETF Overview
Overview
The Global X Aging Population ETF (GNGE) seeks to invest in companies that stand to benefit from the demographic trend of an aging global population, focusing on sectors like healthcare, senior living, and specialized consumer goods and services.
Reputation and Reliability
Global X ETFs is known for its thematic ETFs and is generally considered a reputable issuer with a solid track record.
Management Expertise
Global X ETFs has a dedicated team of investment professionals with expertise in thematic investing and ETF management.
Investment Objective
Goal
To provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Indxx Global Longevity Thematic Index.
Investment Approach and Strategy
Strategy: GNGE aims to track the Indxx Global Longevity Thematic Index, a benchmark designed to capture companies poised to benefit from the aging global population.
Composition The ETF holds a basket of stocks primarily in developed markets, focusing on companies in healthcare, pharmaceuticals, biotechnology, senior living, and related industries.
Market Position
Market Share: Data Unavailable
Total Net Assets (AUM): 21550000
Competitors
Key Competitors
- LONR
- LIVV
- OLD
Competitive Landscape
The competitive landscape includes ETFs focused on longevity, healthcare innovation, and retirement income. GNGE distinguishes itself through its specific focus on companies benefiting directly from the aging population trend. Advantages include a targeted thematic approach, while disadvantages could involve sector concentration risk compared to broader healthcare ETFs.
Financial Performance
Historical Performance: Historical performance data should be obtained from reliable financial data sources.
Benchmark Comparison: Performance should be compared to the Indxx Global Longevity Thematic Index.
Expense Ratio: 0.005
Liquidity
Average Trading Volume
The average trading volume provides an insight into how easily the ETF shares can be bought or sold without significantly impacting the price.
Bid-Ask Spread
A narrow bid-ask spread indicates high liquidity, resulting in lower transaction costs.
Market Dynamics
Market Environment Factors
Economic indicators such as interest rates, inflation, and global growth, as well as the aging population trend, healthcare spending, and technological advancements in medical care, can all impact GNGE.
Growth Trajectory
Growth trends are driven by the increasing global aging population, advancements in healthcare technologies, and shifts in consumer spending patterns towards senior-focused products and services.
Moat and Competitive Advantages
Competitive Edge
GNGE's competitive edge lies in its highly targeted thematic approach, focusing specifically on the aging population. This niche market focus allows investors to gain exposure to companies directly benefiting from this demographic trend. Global X's expertise in thematic investing also provides a competitive advantage. The focused approach may appeal to investors looking for targeted exposure within the broader healthcare or consumer discretionary sectors.
Risk Analysis
Volatility
GNGE's volatility depends on the volatility of its underlying holdings, particularly in the healthcare and consumer discretionary sectors. Analyze historical price fluctuations to assess risk.
Market Risk
Specific risks include market risk, sector concentration risk (healthcare and consumer discretionary), and the risk that the aging population theme may not play out as expected.
Investor Profile
Ideal Investor Profile
The ideal investor is one seeking long-term growth potential tied to the aging global population. Investors who believe in the longevity theme and are comfortable with sector concentration are suitable.
Market Risk
GNGE is best suited for long-term investors seeking thematic exposure. It may not be ideal for active traders due to its niche focus.
Summary
The Global X Aging Population ETF (GNGE) provides targeted exposure to companies benefiting from the global aging trend. Its thematic approach distinguishes it from broader healthcare ETFs. Risks include sector concentration and market risk. It's suitable for long-term investors who believe in the longevity theme. GNGE provides a focused investment opportunity in a growing demographic trend.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Global X ETFs website
- ETF.com
- Morningstar
- Bloomberg
Disclaimers:
The data and analysis provided are for informational purposes only and should not be considered investment advice. Investment decisions should be based on your own research and risk tolerance.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Global X Aging Population ETF
Exchange NASDAQ | Headquaters - | ||
IPO Launch date - | CEO - | ||
Sector - | Industry - | Full time employees - | Website |
Full time employees - | Website |
The fund invests more than 80% of its total assets in the securities of the underlying index. The underlying index is designed to provide exposure to exchange-listed companies in developed markets that facilitate the demographic trend of longer average life spans and the aging of the global population, including but not limited to companies involved in biotechnology, medical devices, pharmaceuticals, senior living facilities and specialized health care services.

Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.